Biomerieux SA - Unsponsored ADR (BMXXY)
OTC
8.23
-0.33 (-3.87%)
Closed
Aug 21, 2026
Day's Range
8.238.23
52 wk Range
7.1215.61
Financial Statements - BMXXY - Biomerieux SA - Unsponsored ADR
Revenue
4.06B▲ 2.3%
Net Income
396.90M▼ 6.6%Net Margin 9.8%
EBITDA
1.03B▲ 8.8%
Free Cash Flow
453.10M▲ 40.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.06B | 3.97B | 3.67B | 4.21B | 3.37B | 3.11B |
| Cost of Goods | 1.76B | 1.76B | 1.61B | 1.85B | 1.37B | 1.36B |
| Gross Profit | 2.30B | 2.21B | 2.05B | 2.35B | 2B | 1.75B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 694.70M | 637.90M | 568.90M | 734.12M | 844M | 612.40M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 525.70M | 579.30M | 437.50M | 681.08M | 774.50M | 524.40M |
| Income Tax | 128.80M | 154.30M | 114.50M | 164.37M | 175.60M | 121.50M |
| Net Income | 396.90M | 425.10M | 322.80M | 516.82M | 598.20M | 402.70M |
| EPS Basic | 0.337 | 0.367 | 0.303 | 0.384 | 0.508 | 0.342 |
| EPS Diluted | 0.334 | 0.364 | 0.301 | 0.382 | 0.506 | 0.341 |
| Basic Shares Outstanding | 1.17B | 1.17B | 1.18B | 1.38B | 1.13B | 1.13B |
| Diluted Shares Outstanding | 1.17B | 1.17B | 1.18B | 1.38B | 1.13B | 1.13B |
| Ebit | 541.50M | 595.30M | 453.30M | 685.89M | 783.60M | 549.30M |
| Ebitda | 1.03B | 948.30M | 841.80M | 1.02B | 1.09B | 825.40M |
| Net Income Continuous Operations | 396.90M | 425.10M | 322.80M | 516.82M | 598.20M | 402.70M |
| Minority Interests | 600K | 7.10M | 34.80M | 11.80M | 2.90M | 1.70M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
